The table below shows Palvella Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
-
-
-
-
$0.00
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$9.33M
$6.53M
$5.12M
$4.07M
$3.18M
$1.44M
SG&A
PVLA annual revenue (10-K history)
Palvella Therapeutics, Inc. reported annual revenue of $42.81M for fiscal year 2023. That is up 65.3% from $25.90M in fiscal 2022. Over the 10 fiscal years shown, annual revenue grew from $5.37M (FY 2014) to $42.81M. Figures come from the company's audited annual reports as filed with the SEC.